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The Editorial on the Research Topic
Protein Interaction Networks in Health and Disease
The identification and annotation of protein-protein interactions (PPIs) is of great importance in
systems biology. Big data produced from experimental or computational approaches allow not only
the construction of large protein interaction maps but also expand our knowledge on how proteins
build up molecular complexes to perform sophisticated tasks inside a cell. However, if we want
to accurately understand the functionality of these complexes, we need to go beyond the simple
identification of PPIs. We need to know when and where an interaction happens in the cell and
also understand the flow of information through a protein interaction network.
Another perspective of the research on PPI networks is the study of their relation to disease.
In disease conditions, mutations that alter the secondary structure of one protein might perturb
its PPIs, as well. Thereafter many things can go wrong via cascading effects, caused by the inter-
relatedness of the mutated protein to other proteins through the PPI network. Such perturbations
could block the formation of a protein complex or lead to the formation of new protein
complexes and the activation of abnormal signaling pathways. These events could alter the cellular
transcriptome profile and further contribute to disease pathogenesis. That is why the maintenance
of the proper structure and functionality of a PPI network is crucial for cellular homeostasis. Its
disruption can cause complex effects and understanding them requires advanced methods for
analysis.
The aim of this Research Topic is to present novel findings and recent achievements in the
field of PPI networks. Thematically, it is divided into two parts. First, we present methods for
the identification and quantification of PPIs; second, we describe computational approaches to
annotate interactomes and extract information related to disease prediction or disease progression.
The first four articles deal with the identification and quantification of PPIs. In the first work,
Suter et al. describe the application of next generation sequencing (NGS) for the characterization
of binary PPIs. Authors present an accurate method to analyze yeast two-hybrid data by NGS and
also interpret interaction data via quantitative statistics. They also discuss how this methodology
can be used to discover differential PPIs allowing the identification of disease mechanisms
(Suter et al.).
The next two review articles describe mass spectrometry (MS) based approaches. Yang
et al. present methods that can determine the relative abundance of purified proteins in
a sample enabling the identification of transient PPIs in different conditions. Additionally,
when combined with proximity tagging methods, MS may illuminate spatial or temporal
PPIs, especially those of signaling pathways whose perturbation may underlie human diseases
(Yang et al.). Meyer and Selbach indicate how MS can be used to identify dynamic changes
in the interactome. Stable isotope labeling in aminoacids and affinity purification-MS can
shed light on the dynamic behavior of proteins even at different stages of an experiment
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following perturbation. Authors also describe how MS may
identify the stoichiometry of proteins in complexes. These
methodologies can be employed to study the dynamic changes of
PPIs under normal and disease conditions (Meyer and Selbach).
In the next article, Buntru et al. review novel cell-based
assays for the detection of PPIs and discuss their strengths
and weaknesses. Compared to traditional genetic or biochemical
methods, these techniques provide quantitative information of
PPIs even in the context of living cells. This information
can be used to prioritize a large number of PPIs, allowing
researchers to better describe the biological systems and
improve our understanding of disease processes (Buntru et
al.).
The second part of the Research Topic is comprised of
seven papers dealing with the annotation of protein interaction
networks. Alanis-Lobato describes computational mining tools
to improve the reliability of protein networks and predict new
interactions based on the topological characteristics of their
components. He also provides examples on how the integration
of clinical data can highlight disease modules in these networks
or indicate similarities between diseases (Alanis-Lobato).
Pelassa and Fiumara study the functional role of
homopolymeric amino acid repeats (AARs) in proteins and
their PPIs. AARs are considered to mediate PPIs and in some
cases correlate with human diseases, such as polyglutamine
expansions involved in Huntington’s disease. The authors
describe a computational screening of the human interactome
and show that AAR-containing network components have a high
degree of connectivity. They also indicate an overlap between
AARs and interaction domains suggesting that AARs play an
important role in shaping protein interaction networks (Pelassa
and Fiumara).
Lecca and Re present WG-Cluster, a novel algorithm for
the detection of modular structures in protein networks. This
tool combines network node and edge weight information of
connected proteins improving the biological interpretability of a
PPI. The authors also apply their technique in biological datasets
from patients with colorectal cancer and indicate differentially
active cellular processes in normal vs. tumor conditions (Lecca
and Re).
In the next article, Chen and colleagues use the dynamical
network biomarkers method to detect early disease signals in a
breast cancer cell model. The authors pinpoint critical network
changes and highlight a number of pathways associated with the
pre-transition from the normal state to a cancer cell progression
stage. They also suggest the use of these signals as targets for
disease intervention (Chen et al.).
Databases collecting data on experimentally verified PPIs are
a valuable resource for the research community. In particular,
there are studies that extract biological knowledge from analysis
of these global data. However, the different intensity with which
different proteins have been studied, influences the amount
of data that is available for certain proteins leading to wrong
statements. Schaefer et al. study the biases that affect the human
PPI data due to research heterogeneity, propose measures to
correct this and show an application to proteins involved in
cancer.
Yeger-Lotem and Sharan present computational approaches
to construct tissue or disease-specific interactomes. They indicate
how the combination of transcriptome profiles with proteomics
data could categorize PPIs from large networks according to their
occurrence in specific tissues. In parallel, they present the effect of
disease-causing mutations on protein stability and subsequently
on the integrity and structure of protein networks in an affected
tissue (Yeger-Lotem and Sharan).
In the last article of this topic, Theofilatos et al. argue about
the challenges of computational analysis of PPI data and present
future goals such as biomarker discovery or identification of
pathogenic PPIs and their drug targeting. Authors also support
that the integration of environmental or clinical data in protein
networks will allow their in-depth study and the construction of
personalized interactomes (Theofilatos et al.).
In the past decade, network biology focused on the
representation of the binary interaction of proteins. Today, the
field of PPI research capitalizes and hops above the establishment
of such previous work and resources, identifies existing
limitations, and proposes further avenues of investigation, as
reflected in this Frontiers Research Topic. A tight connection
between experimental and computational efforts is a hallmark
of the articles that we present here, which set the tone
that PPI research will follow in the next years. If anything
remains unchanged, this is our awareness of the fact that
diseases are often caused by the malfunction of large protein
complexes. This holds as the main motivation of research
in the field, which screams for more complete and reliable
interactomes, ultimately crucial in order to identify relevant
pathogenic mechanisms and design therapeutic intervention
strategies.
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